Sep 7, 2026, 15:35
Abdulaziz Hamoudi: The Multicenter Randomized PROTECT-EST Trial Reports Impressive Results for SAP
Abdulaziz Hamoudi, Business Development Manager at ENDOHUB group, shared a post on LinkedIn:
”Peptide-first for post-sphincterotomy bleeding?
The multicenter randomized PROTECT-EST trial reports impressive results for self-assembling peptide (SAP) in persistent post-sphincterotomy oozing:
- 92.3 percent immediate hemostasis vs 76.9 percent with balloon tamponade
- 7.7 percent required rescue therapy vs 23.1 percent
Promising evidence supporting a peptide-first strategy in therapeutic endoscopy.
Proud to support the advancement of PuraStat self-assembling peptide technology in our region.
Study.”
Stay updated with Hemostasis Today.
-
Sep 7, 2026, 15:33Antoinette Doherty: Evaluating CTPA Referrals to Drive Quality Improvement in PE Diagnosis
-
Sep 7, 2026, 15:31Haroon Gul Khan: Critical Evaluation of DVT Cross-Referencing
-
Sep 7, 2026, 15:26Rick Matthews: Venous Thromboembolism Treatment Isn’t the Same For Everyone
-
Sep 7, 2026, 15:20Andrew Jones: Platelet Count Is Only One Dimension of Hemostatic Function
-
Sep 7, 2026, 15:10Can Novel Anticoagulants Reduce Thrombosis Without Increasing Bleeding – JTH
-
Sep 7, 2026, 15:09Kashis Gupta: Excited to Share My AI/ML Project – Anemia Fusion Net!
-
Sep 7, 2026, 15:08Adam Urato: The Platelet Paradox of SSRIs
-
Sep 7, 2026, 15:00Haroon Gul Khan: Why Critical Reading Matters in Medical Education
-
Sep 7, 2026, 14:59Ahmed Mahmoud: Vitamin B12 Deficiency Can Present Far Beyond Fatigue and Macrocytic Anemia